Abstract
Purpose
To investigate the effect of prior chemotherapy on self-expanding metal stent (SEMS)-related complications in patients with locally advanced primary esophageal cancer.
Materials and methods
Data from patients with locally advanced primary esophageal cancer who received SEMS placement with or without prior chemotherapy were retrospectively reviewed. Patients were grouped according to prior palliative therapy: group A (n = 41) had received SEMS only, and group B (n = 64) had received palliative chemotherapy prior to SEMS placement. Patients’ age, stricture length, tumor location, and dysphagia score prior to SEMS placement were evaluated. The overall patient cohort had a median follow-up period of 129 days (range 11–463). Outcomes after SEMS placement, including technical and clinical success rates, the occurrence of complications, and overall survival, were compared.
Results
There were no significant differences between the two groups regarding patients’ age, stricture length, tumor location, and dysphagia score prior to SEMS placement. SEMS placement was technically successful in all patients, with no procedure-related complications reported. Clinical success was achieved in 95.1% of patients in group A and 96.8% of patients in group B. The duration of stent patency was significantly shorter in group B [162 days; 95% confidence interval (CI) 126.6–198.4 vs. group A (339 days; 95% CI 258.8–419.3], p = 0.001. No significant differences were seen between the two groups regarding dysphagia score improvement [group A (3.15 ± 0.57 to 1.17 ± 0.83; p < 0.001) and group B (3.17 ± 0.80 to 1.14 ± 0.79; p < 0.001); p = 0.66], complications [group A (10/41), and group B (24/64); p = 0.094], or overall survival [the median and mean overall survival periods were 105 (95% CI 30–180) and 132 days (95% CI 97–167), respectively, in group A, and 126 (95% CI 88–164) and 156 days (95% CI 132–180), respectively, in group B; p = 0.592].
Conclusion
Prior chemotherapy did not increase the risk of complications following SEMS placement in patients with locally advanced esophageal cancer. SEMS patency was significantly longer in patients who did not receive chemotherapy prior to SEMS placement.
Level of Evidence
Level 4, Case Series.
Similar content being viewed by others
Abbreviations
- 5-FU:
-
5-Fluorouracil
- CI:
-
Confidence interval
- HR:
-
Hazard ratio
- OR:
-
Odds ratio
- SEMSs:
-
Self-expandable metallic stents
References
Rustgi AK, El-Serag HB (2014) Esophageal carcinoma. The New England journal of medicine 371 (26):2499–2509. https://doi.org/10.1056/nejmra1314530
Medeiros VS, Martins BC, Lenz L, Ribeiro MSI, de Paulo GA, Lima MS, Safatle-Ribeiro AV, Kawaguti FS, Pennacchi C, Geiger SN, Bastos VR, Ribeiro-Junior U, Sallum RA, Maluf-Filho F (2017) Adverse events of self-expandable esophageal metallic stents in patients with long-term survival from advanced malignant disease. Gastrointestinal endoscopy 86 (2):299–306. https://doi.org/10.1016/j.gie.2016.12.017
Fuccio L, Scagliarini M, Frazzoni L, Battaglia G (2016) Development of a prediction model of adverse events after stent placement for esophageal cancer. Gastrointestinal endoscopy 83 (4):746–752. https://doi.org/10.1016/j.gie.2015.08.047
Lai A, Lipka S, Kumar A, Sethi S, Bromberg D, Li N, Shen H, Stefaniwsky L, Brady P (2018) Role of Esophageal Metal Stents Placement and Combination Therapy in Inoperable Esophageal Carcinoma: A Systematic Review and Meta-analysis. Digestive diseases and sciences 63 (4):1025–1034. https://doi.org/10.1007/s10620-018-4957-z
Nagaraja V, Cox MR, Eslick GD (2014) Safety and efficacy of esophageal stents preceding or during neoadjuvant chemotherapy for esophageal cancer: a systematic review and meta-analysis. Journal of gastrointestinal oncology 5 (2):119–126. https://doi.org/10.3978/j.issn.2078-6891.2014.007
Sumiyoshi T, Gotoda T, Muro K, Rembacken B, Goto M, Sumiyoshi Y, Ono H, Saito D (2003) Morbidity and mortality after self-expandable metallic stent placement in patients with progressive or recurrent esophageal cancer after chemoradiotherapy. Gastrointestinal endoscopy 57 (7):882–885. https://doi.org/10.1067/mge.2003.234
Lu YF, Chung CS, Liu CY, Shueng PW, Wu LJ, Hsu CX, Kuo DY, Hou PY, Chou HL, Leong KI, How CH, Chou SF, Wang LY, Hsieh CH (2018) Esophageal Metal Stents with Concurrent Chemoradiation Therapy for Locally Advanced Esophageal Cancer: Safe or Not? The oncologist. https://doi.org/10.1634/theoncologist.2017-0646
Lecleire S, Di Fiore F, Ben-Soussan E, Antonietti M, Hellot MF, Paillot B, Lerebours E, Ducrotte P, Michel P (2006) Prior chemoradiotherapy is associated with a higher life-threatening complication rate after palliative insertion of metal stents in patients with oesophageal cancer. Alimentary pharmacology & therapeutics 23 (12):1693–1702. https://doi.org/10.1111/j.1365-2036.2006.02946.x
Shin JH, Song HY, Kim JH, Kim SB, Lee GH, Park SI, Han YM, Kang W (2005). Comparison of temporary and permanent stent placement with concurrent radiation therapy inpatients with esophageal carcinoma. J Vasc Interv Radiol. 16(1):67–74.
Shin JH, Song H-Y, Kim JH, Kim S-B, Lee GH, Park S-I, Han Y-M, Kang W (2005) Comparison of Temporary and Permanent Stent Placement with Concurrent Radiation Therapy in Patients with Esophageal Carcinoma. Journal of Vascular and Interventional Radiology 16 (1):67–74. https://doi.org/10.1097/01.rvi.0000142585.90055.74
Spaander MC, Baron TH, Siersema PD, Fuccio L, Schumacher B, Escorsell A, Garcia-Pagan JC, Dumonceau JM, Conio M, de Ceglie A, Skowronek J, Nordsmark M, Seufferlein T, Van Gossum A, Hassan C, Repici A, Bruno MJ (2016) Esophageal stenting for benign and malignant disease: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline. Endoscopy 48 (10):939–948. https://doi.org/10.1055/s-0042-114210
Park JY, Shin JH, Song HY, Yi SY, Kim JH (2012) Airway complications after covered stent placement for malignant esophageal stricture: special reference to radiation therapy. AJR American journal of roentgenology 198 (2):453–459. https://doi.org/10.2214/ajr.10.5780
Iwasaki H, Mizushima T, Suzuki Y, Fukusada S, Kachi K, Ozeki T, Anbe K, Tsukamoto H, Okumura F, Joh T, Sano H (2017) Factors That Affect Stent-Related Complications in Patients with Malignant Obstruction of the Esophagus or Gastric Cardia. Gut and liver 11 (1):47–54. https://doi.org/10.5009/gnl16172
Dai Y, Li C, Xie Y, Liu X, Zhang J, Zhou J, Pan X, Yang S (2014) Interventions for dysphagia in oesophageal cancer. The Cochrane database of systematic reviews (10):CD005048. https://doi.org/10.1002/14651858.cd005048.pub4
Song H-Y, Lee DH, Seo T-S, Kim S-B, Jung H-Y, Kim J-H, Park S-I (2002) Retrievable Covered Nitinol Stents: Experiences in 108 Patients with Malignant Esophageal Strictures. Journal of Vascular and Interventional Radiology 13 (3):285–292. https://doi.org/10.1016/s1051-0443(07)61722-9
Kim KY, Tsauo J, Song HY, Kim PH, Park JH (2017) Self-Expandable Metallic Stent Placement for the Palliation of Esophageal Cancer. Journal of Korean medical science 32 (7):1062–1071. https://doi.org/10.3346/jkms.2017.32.7.1062
Kim KY, Tsauo J, Song HY, Park JH, Jun EJ, Zhou WZ, Kim MT (2017) Evaluation of a New Esophageal Stent for the Treatment of Malignant and Benign Esophageal Strictures. Cardiovascular and interventional radiology 40 (10):1576–1585. https://doi.org/10.1007/s00270-017-1677-2
Park JH, Song HY, Park JY, Kim JH, Kim YH, Kim JH, Kim SB (2013) Temporary stent placement with concurrent chemoradiation therapy in patients with unresectable oesophageal carcinoma: is there an optimal time for stent removal? European radiology 23 (7):1940–1945. https://doi.org/10.1007/s00330-013-2786-1
Park JH, Song HY, Kim JH, Jung HY, Kim JH, Kim SB, Lee H (2012) Polytetrafluoroethylene-covered retrievable expandable nitinol stents for malignant esophageal obstructions: factors influencing the outcome of 270 patients. AJR American journal of roentgenology 199 (6):1380–1386. https://doi.org/10.2214/ajr.10.6306
Sacks D, McClenny TE, Cardella JF, Lewis CA (2003) Society of Interventional Radiology Clinical Practice Guidelines. Journal of Vascular and Interventional Radiology 14 (9):S199–S202. https://doi.org/10.1097/01.rvi.0000094584.83406.3e
Didden P, Reijm AN, Erler NS, Wolters LMM, Tang TJ, Ter Borg PCJ, Leeuwenburgh I, Bruno MJ, Spaander MCW (2018) Fully vs. partially covered selfexpandable metal stent for palliation of malignant esophageal strictures: a randomized trial (the COPAC study). Endoscopy 50 (10):961–971. https://doi.org/10.1055/a-0620-8135
Homs MY, Hansen BE, Blankenstein MV, Haringsma J, Kuipers EJ, Siersema PD (2004) Prior radiation and/or chemotherapy has no effect on the outcome of metal stent placement for oesophagogastric carcinoma. European Journal of Gastroenterology & Hepatology 16 (2):163–170. https://doi.org/10.1097/00042737-200402000-00007
Iraha Y, Murayama S, Toita T, Utsunomiya T, Nagata O, Akamine T, Ogawa K, Adachi G, Tanigawa N (2006) Self-expandable metallic stent placement for patients with inoperable esophageal carcinoma: investigation of the influence of prior radiotherapy and chemotherapy. Radiation medicine 24 (4):247–252. https://doi.org/10.1007/s11604-005-1539-8
Pellen MG, Sabri S, Razack A, Gilani SQ, Jain PK (2012) Safety and efficacy of self-expanding removable metal esophageal stents during neoadjuvant chemotherapy for resectable esophageal cancer. Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus 25 (1):48–53. https://doi.org/10.1111/j.1442-2050.2011.01206.x
Siddiqui AA, Sarkar A, Beltz S, Lewis J, Loren D, Kowalski T, Fang J, Hilden K, Adler DG (2012) Placement of fully covered self-expandable metal stents in patients with locally advanced esophageal cancer before neoadjuvant therapy. Gastrointestinal endoscopy 76 (1):44–51. https://doi.org/10.1016/j.gie.2012.02.036
Wlodarczyk J, Kuzdzal J (2016) Stenting as a palliative method in the management of advanced squamous cell carcinoma of the oesophagus and gastro-oesophageal junction. Wideochirurgia i inne techniki maloinwazyjne = Videosurgery and other miniinvasive techniques 11 (1):1–8. https://doi.org/10.5114/wiitm.2016.58979
Ross WA, Alkassab F, Lynch PM, Ayers GD, Ajani J, Lee JH, Bismar M (2007) Evolving role of self-expanding metal stents in the treatment of malignant dysphagia and fistulas. Gastrointestinal endoscopy 65 (1):70–76. https://doi.org/10.1016/j.gie.2006.04.040
Sharma P, Kozarek R, Practice Parameters Committee of American College of G (2010) Role of esophageal stents in benign and malignant diseases. The American journal of gastroenterology 105 (2):258–273; quiz 274. https://doi.org/10.1038/ajg.2009.684
Funding
This study was supported by a Grant from the Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (Grant No. HI15C0484 to H.Y.S.).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflicts of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the Ethical Standards of the Institutional Research Committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Informed consent
This study has obtained institutional IRB approval and the need for informed consent was waived.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Nader Bakheet and Hong-Tao Hu are co-first authors.
Rights and permissions
About this article
Cite this article
Bakheet, N., Hu, HT., Park, JH. et al. Clinical effectiveness and safety of self-expanding metal stent placement following palliative chemotherapy in patients with advanced esophageal cancer. Abdom Radiol 45, 563–570 (2020). https://doi.org/10.1007/s00261-019-02245-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00261-019-02245-3